PLATELET TARGETED THERAPEUTICS LLC has a total of 12 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are WNTRX PHARMACEUTICALS INC, PROTOX THERAPEUTICS INC and SYNTHON BIOPHARMACEUTICALS BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Hong Kong | 1 | |
#6 | Israel | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Haberichter Sandra L | 7 |
#2 | Wilcox David A | 7 |
#3 | Sandra L Haberichter | 3 |
#4 | David A Wilcox | 3 |
#5 | Haberichter Sandra L L | 1 |
#6 | Wilcox David A A | 1 |
Publication | Filing date | Title |
---|---|---|
US2015344541A1 | Platelet targeted treatment |